Mavens Biotech inches ahead on stock split proposal

Mavens Biotech gained 0.16% to Rs 611 at 14:32: IST on BSE after the company said its board has approved a 10-for-1 stock split.

The stock hit a high of Rs 615.90 and a low of Rs 610.50 so far during the day. The stock had a 52-week high of Rs 617.50 on 17 June 2008 and a 52-week low of Rs 580 on 9 May 2008.

The company has an equity capital of Rs 10.99 crore. Face value per share is Rs 10.

The current price of Rs 611 discounts its Q1 March 2008 annualised EPS of Rs 2.07, by a

PE multiple of 295.17.

Mavens Biotech’s net profit rose 1325% to Rs 0.57 crore on 55.2% increase in net sales to Rs 7.45 crore in Q4 March 2008 over Q4 March 2007.

Mavens Biotech is a plant biotechnology company with two key business areas viz., bioinformatics and plant tissue culture unit.